Skip to content

Ketamine research published in 2024

Page 17 of 26: studies 321 to 340 of 518, newest first. Back to the ketamine overview

Studies

Ketamine reverses stress-induced hypersensitivity to sunk costs.

bioRxiv : the preprint server for biology May 14, 2024 Romain Durand-De Cuttoli, Brian M Sweis 1 citation preprint

How mood interacts with information processing in the brain is thought to mediate the maladaptive behaviors observed in depressed individuals. However, the neural mechanisms underlying impairments in emotion-cognition interactions are poorly understood. This includes influencing the balance between how past-sensitive vs. future-looking one is during decision-making. Recent insights from the...

DOI: 10.1101/2024.05.12.593597 (opens in new tab) Full text (opens in new tab) Behavioral-economics Mental-health Decision-making Stress-management

Ketamine Usage Effectivity on Treatment-Resistant Depression Diagnosed Patients: a Scoping Review

Jurnal Psikiatri Surabaya May 13, 2024 Satrio Wahyu Nugroho, Agustina Konginan, Gadis Meinar Sari et al. 1 citation

Introductions: In Indonesia, a median of 6.1% of people diagnosed with depression disorder are people over 15 years old. Only 9% of that amount underwent medical treatment, while the rest, 91%, did not undergo treatment for their depressive conditions. Inadequate and inappropriate treatment of depression will lead to Treatment-Resistant Depression (TRD). Using ketamine as a pharmacotherapy...

Hype or hope? Ketamine for the treatment of depression: results from the application of deep learning to Twitter posts from 2010 to 2023

Frontiers in Psychiatry May 10, 2024 Qin Xiang Ng, Yu Liang Lim, Clarence Ong et al. 3 citations

Objective: To investigate societal perceptions of ketamine's use in depression therapy by analysing Twitter posts from January 1, 2010 to April 1, 2023. Methods: Using Twitter as the social media platform of choice, and employing search terms based on (depression OR depressed OR depressive) AND (ketamine OR esketamine OR Spravato), we collected English-language tweets from January 1, 2010, to...

DOI: 10.3389/fpsyt.2024.1369727 (opens in new tab) Ketamine Social media Microblogging Thematic analysis +6

Guidelines for ketamine use in clinical psychiatry practice.

BJPsych Open May 10, 2024 Luke A. Jelen, Rupert McShane, Allan H. Young 7 citations

In this editorial, we emphasise the efficacy and challenges of using ketamine in treatment-resistant depression. We highlight the need for comprehensive evidence-based guidelines to manage the use of both licensed and off-licence ketamine formulations and discuss recent efforts by Beaglehole et al to develop ketamine guidelines in New Zealand. We finally advocate for national registries to...

Rapid and sustained antidepressant effects of intravenous ketamine in treatment-resistant major depressive disorder and suicidal ideation: a randomized clinical trial.

BMC Psychiatry May 7, 2024 Ahmad Zolghadriha, Afagh Anjomshoaa, Mohammad Reza Jamshidi et al. 24 citations Retracted

Major depressive disorder (MDD) is the most disabling and burdensome mental disorder, negatively affecting an individual's quality of life and daily functioning. the current study was conducted with the aim of investigating the clinical effects of intravenous ketamine on symptoms of MDD and suicidal ideation. The current randomized clinical trial was carried out on 64 patients diagnosed with...

Exploring effects and experiences of ketamine in group couples therapy

Journal of Psychedelic Studies May 6, 2024 Mark Cornfield, S. Mcbride, Joseph T. la Torre et al. 6 citations

This study contributes to the understanding of the efficacy, safety, and experience of ketamine-assisted therapy. The paper documents how individuals describe the effects of a protocolized and personalized use of ketamine (‘the relational dose’) in the context of group couples therapy based on Imago Relationship Therapy (IRT). Little is known about simultaneously administering ketamine to both...

Therapeutic doses of ketamine acutely attenuate the aversive effect of losses during decision-making.

Elife May 3, 2024 Mariann Oemisch, Hyojung Seo

The discovery of rapid-acting antidepressant, ketamine has opened a pathway to a new generation of treatments for depression, and inspired neuroscientific investigation based on a new perspective that non-adaptive changes in the intrinsic excitatory and inhibitory circuitry might underlie the pathophysiology of depression. Nevertheless, it still remains largely unknown how the hypothesized...

DOI: 10.7554/elife.87529 (opens in new tab) Full text (opens in new tab) Nmda receptor Affective memory Negative valence Reinforcement learning +5

Ketamine-induced prevention of SD-associated late infarct progression in experimental ischemia.

Scientific Reports May 3, 2024 A Zdunczyk, L Schumm, S O A Helgers et al. 5 citations

Spreading depolarizations (SDs) occur frequently in patients with malignant hemispheric stroke. In animal-based experiments, SDs have been shown to cause secondary neuronal damage and infarct expansion during the initial period of infarct progression. In contrast, the influence of SDs during the delayed period is not well characterized yet. Here, we analyzed the impact of SDs in the delayed...

DOI: 10.1038/s41598-024-59835-5 (opens in new tab) Full text (opens in new tab) Experimental ischemia Stroke progression Stroke treatment Neuroprotection +3

Substance specific EEG patterns in mice undergoing slow anesthesia induction.

BMC Anesthesiology May 3, 2024 David P Obert, David Killing, Tom Happe et al. 5 citations

The exact mechanisms and the neural circuits involved in anesthesia induced unconsciousness are still not fully understood. To elucidate them valid animal models are necessary. Since the most commonly used species in neuroscience are mice, we established a murine model for commonly used anesthetics/sedatives and evaluated the epidural electroencephalographic (EEG) patterns during slow...

Ketamine Crisis: Case Report on the Complications of Ketamine Usage and Its Rise in the United States

Research Posters May 2, 2024 Shika Veera, Vajreshwar Shivaprakash

The recreational use of ketamine poses various health risks, including addiction, cognitive impairments, and physical harm. The patient is a 24-year-old female who presented with 30 lbs. unintentional weight loss, generalized weakness, and urinary incontinence over four months. She endorses right upper quadrant and suprapubic pain with occasional gross hematuria. The patient denied recreational...

Ketamine for Postpartum Depression: A Systematic Review

Research Posters May 2, 2024 Jaylyn Thompson, David F Lo, Alexis Foschini et al.

The purpose of this review is to explore perinatal ketamine’s potential for reducing postpartum depression after cesarean section. Articles reviewed from Pubmed, Cochrane, and Web of Science using specific search terms. 8 final papers were used for review after excluding duplicates and irrelevant titles and abstracts. Ketamine showed potential in reducing postpartum depression symptoms post...

Exploring Cultural Competence, Inclusivity, and Diversity in Ketamine Assisted Psychotherapy: A Phenomenological Study.

Journal of Psychoactive Drugs May 2, 2024 Dave Rojas, Diane C Zelman, Alexander O Hauson et al. 2 citations

Black, Indigenous, and People of Color (BIPOC), and other minoritized populations are insufficiently represented in research on therapeutic psychedelics. This research was a phenomenological qualitative exploration of a culturally diverse (Hispanic, African American, Asian, Native American, biracial, or LGBTQIA+) and low-income sample of 15 individuals receiving ketamine-assisted psychotherapy...

Effect of Repeated Intravenous Esketamine on Adolescents With Major Depressive Disorder and Suicidal Ideation: A Randomized Active-Placebo-Controlled Trial.

Journal of the American Academy of Child & Adolescent Psychiatry May 2024 Yanling Zhou, Xiaofeng Lan, Chengyu Wang et al.

Suicide is a major cause of death in adolescents with limited treatment options. Ketamine and its enantiomers have shown rapid anti-suicidal effects in adults with major depressive disorder (MDD), but their efficacy in adolescents is unknown. We conducted an active, placebo-controlled trial to determine the safety and efficacy of intravenous esketamine in this population. A total of 54...

State-related Electroencephalography Microstate Complexity during Propofol- and Esketamine-induced Unconsciousness.

Anesthesiology May 1, 2024 Zhenhu Liang, Bo Tang, Yu Chang et al. 13 citations

Identifying the state-related "neural correlates of consciousness" for anesthetics-induced unconsciousness is challenging. Spatiotemporal complexity is a promising tool for investigating consciousness. The authors hypothesized that spatiotemporal complexity may serve as a state-related but not drug-related electroencephalography (EEG) indicator during an unconscious state induced by different...

A role of gut-brain axis on prophylactic actions of arketamine in male mice exposed to chronic restrain stress.

Pharmacology, Biochemistry, and Behavior May 1, 2024 Li Ma, Akifumi Eguchi, Guilin Liu et al. 11 citations

The gut-brain axis, which includes gut microbiota and microbiome-derived metabolites, might be implicated in depression. We reported the sustained prophylactic effects of a new antidepressant arketamine in chronic restrain stress (CRS) model of depression. In this study, we investigated the role of gut-brain axis on the prophylactic effects of arketamine in the CRS (7 days) model. Pretreatment...

DOI: 10.1016/j.pbb.2024.173736 (opens in new tab) Full text (opens in new tab) Chronic restrain stress Gut microbiota Metabolites Prophylactic effect: resilience +5

Change in neurocognitive functioning in patients with treatment-resistant depression with serial intravenous ketamine infusions: The Bio-K multicenter trial.

Psychiatry Research May 1, 2024 Balwinder Singh, Sagar V Parikh, Jennifer L. Vande Voort et al. 18 citations

This nonrandomized, multicenter, open-label clinical trial explored the impact of intravenous (IV) ketamine on cognitive function in adults (n = 74) with treatment-resistant depression (TRD). Patients received three IV ketamine infusions during the acute phase and, if remitted, four additional infusions in the continuation phase (Mayo site). Cognitive assessments using the Repeatable Battery...

DOI: 10.1016/j.psychres.2024.115829 (opens in new tab) Full text (opens in new tab) Neurocognition Open-label study Rbans Ketamine infusion +4

IV low dose ketamine infusions for treatment resistant depression: Results from a five-year study at a free public clinic in an academic hospital.

Psychiatry Research May 1, 2024 Gilmar Gutierrez, Melody J Y Kang, Gustavo Vazquez 12 citations

Individuals with major depressive disorder and treatment resistant depression (MDD-TRD) have limited and sometimes poorly tolerated therapeutic options. Low dose ketamine has presented promising and potent antidepressant effects in this population. To support the existent literature, we conducted a longitudinal study examining five years of real-world clinical data on the use of IV low-dose...

Oral prolonged-release ketamine in treatment-resistant depression - A double-blind randomized placebo-controlled multicentre trial of KET01, a novel ketamine formulation - Clinical and safety results.

Journal of Psychiatric Research May 1, 2024 Michael Colla, Benjamin Offenhammer, Hanne Scheerer et al. 23 citations

We investigated the antidepressant effects of a novel oral prolonged-release formulation of racemic ketamine (KET01) in patients suffering from treatment-resistant depression (TRD) as add-on therapy. Patients were randomized to an additional 160 mg/day or 240 mg/day KET01 or placebo for 14 days. The primary endpoint was change in Montgomery-Åsberg Depression Rating Scale (MADRS) scores from...

DOI: 10.1016/j.jpsychires.2024.03.002 (opens in new tab) Full text (opens in new tab) Depression Ketamine therapy Mental health treatment Clinical trials +1

Predicting non-response to ketamine for depression: An exploratory symptom-level analysis of real-world data among military veterans.

Psychiatry Research May 1, 2024 Eric A. Miller, Houtan Totonchi Afshar, Jyoti Mishra et al. 12 citations

Ketamine helps some patients with treatment resistant depression (TRD), but reliable methods for predicting which patients will, or will not, respond to treatment are lacking. Herein, we aim to inform prediction models of non-response to ketamine/esketamine in adults with TRD. This is a retrospective analysis of PHQ-9 item response data from 120 patients with TRD who received repeated doses of...

Effect of intraoperative and/or postoperative esketamine administration on preventing postpartum depression: A systematic review and meta-analysis.

Psychiatry Research May 1, 2024 Jinping Wang, Hui Liu, Xinchuan Wei 9 citations

This systematic review and meta-analysis aimed to evaluate the impact of intraoperative and/or postoperative esketamine application on the prevention of postpartum depression (PPD). PubMed, Embase, and Web of Science were thoroughly searched for eligible randomized controlled trials (RCTs) regarding the application of esketamine for postnatal depression prevention. Nine RCTs including 1277...

DOI: 10.1016/j.psychres.2024.115890 (opens in new tab) Full text (opens in new tab) Ketamine Postnatal depression Maternal health Mental health treatment +3